NASDAQ:XBIT | Free Cash Flow | XBiotech Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2013-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$8.97M$0.00-$8.97M
2025-12-31-$22.95M$34,000.00-$22.99M
2025-03-31-$6.72M$94,000.00-$6.81M
2024-12-31-$6.54M$84,000.00-$6.62M
2024-03-31-$7.2M$255,000.00-$7.46M
2023-12-31-$3.43M$115,000.00-$3.55M
2023-03-31-$4.81M$6,000.00-$4.81M
2022-12-31-$3.16M$132,000.00-$3.3M
2022-03-31-$5.12M$161,000.00-$5.28M
2021-12-31-$1.76M$476,000.00-$2.24M
2021-03-31$1.81M$637,000.00$1.17M
2020-12-31-$391,000.00$2.22M-$2.61M
2020-03-31-$60.67M$389,000.00-$61.06M
2019-12-31-$3.75M$6,000.00-$3.75M-0.55%
2019-03-31-$4.68M$6,000.00-$4.68M
2018-12-31-$5.12M$8,000.00-$5.12M
2018-03-31-$3.53M$34,000.00-$3.56M
2017-12-31-$6.81M$254,000.00-$7.06M
2017-03-31-$11.91M$607,000.00-$12.52M
2016-12-31-$12.8M$531,000.00-$13.33M
2016-03-31-$9.95M$1.54M-$11.49M
2015-12-31-$10.7M$363,000.00-$11.06M
2015-03-31-$6.53M$152,000.00-$6.68M
2014-12-31-$3.45M$579,000.00-$4.03M
2014-03-31-$2.34M$58,000.00-$2.4M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$39.92M$289,000.00-$40.21M
2024-12-31-$30.96M$1.3M-$32.27M
2023-12-31-$18.73M$362,000.00-$19.09M
2022-12-31-$14.82M$585,000.00-$15.41M
2021-12-31$69.45M$3.53M$65.92M
2020-12-31-$65.15M$3.73M-$68.88M
2019-12-31-$18.27M$204,000.00-$18.47M-2.76%
2018-12-31-$16.54M$122,000.00-$16.66M
2017-12-31-$33.65M$1.41M-$35.05M
2016-12-31-$46.02M$4.75M-$50.76M
2015-12-31-$33.31M$2.32M-$35.63M
2014-12-31-$11.7M$1.4M-$13.1M
2013-12-31-$8.91M$59,000.00-$8.97M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.